Atlas Trials

Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting

Clinical trial NCT05590923 · TERMINATED

Trial details

NCT number
NCT05590923
Sponsor
The Guthrie Clinic
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Chemotherapy-induced Nausea and Vomiting
Start date
2022-12-07
Primary completion
2025-07-08
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.